youtube_live
Q1 2026 earnings • released • EPS beat +4.47% • Revenue beat +1.00%
See resultschevron_right
RVTY:NYSE
Revvity Inc
$101.00
arrow_upward
+2.18%(+2.15) 1D
$101.00
0.00% (0.00)
bedtimeAfter hours
Closed: May 8, 4:00:04 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RVTY...
Open
$99.13
High
$102.23
Low
$94.60
Mkt. cap
11.29B
Avg. vol.
1.17M
Volume
2.44M
52-wk high
$118.30
52-wk low
$81.22
Beta
1.05
Shares outstanding
111.80M
No. of employees
11K
News stories
From sources across the web
AD HOC NEWS
·
10 hours ago
Revvity Inc. stock (US76155R1086): Barclays lifts price target as Q1 beats estimates
Profile
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
About Revvity Inc
CEOPrahlad Singh
Employees11K
Founded1947
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterevvity.com
AI content may include mistakes. Learn more